A COVID-19 vaccine made in Taiwan by Medigen Vaccine Biologics Corp. has received emergency use authorization (EUA) in Paraguay after the unblinding of a Phase 3 clinical trial conducted in the South American country, the company said in a statement Monday.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Society
Magnitude 6.1 earthquake jolts eastern Taiwan
04/27/2024 02:54 AM - Politics
A discussion with Cosette Wu, the woman behind the Harvard speech disruption
04/26/2024 11:25 PM - Society
32 indicted in NT$800 million crypto fraud case
04/26/2024 10:50 PM - Business
Taiwan, U.S. to hold new round of trade talks in Taipei next week: Office
04/26/2024 10:18 PM - Culture
Budapest picked as 2024 Taipei Film Festival's 'City in Focus'
04/26/2024 10:00 PM